Among them, VIP has been proven to act as a negative regulator of differentiation and resorptive activity of rat and mouse osteoclasts [28,29,30,38], demonstrating a protective action on bone destruction in experimentally-induced arthritis [36,37]. This evidence concerns the gene VIP and arthritic joint disease.